Abstract:Globally, prostate cancer remains a leading cause of mortality and morbidity despite advances in treatment. Research on prostate cancer has primarily focused on the malignant epithelium, but the tumor microenvironment has recently been recognized as an important factor in the progression of prostate cancer. Cancer-associated fibroblasts (CAFs) play an important role in prostate cancer progression among multiple cell types in the tumor microenvironment. In order to develop new treatments and identify predictive and prognostic biomarkers for CAFs, further research is needed to understand the mechanism of action of prostate cancer and CAF. In this work, we performed the single-cell RNA sequence analysis to obtain the biomarkers for CAFs, and ten genes were finally regarded as the marker genes for CAFs. Based on the ssGSEA algorithm, the prostate cancer cohort was divided into low- and high-CAFs groups. Further analysis revealed that the CAFs-score is associated with many immune-related cells and immune-related pathways. In addition, between the low- and high-CAFs tissues, a total of 127 hub genes were discovered, which is specific in CAFs. After constructing the prognostic prediction model, SLPI, VSIG2, CENPF, SLC7A1, SMC4, and ITPR2 were finally regarded as the key genes in the prognosis of patients with prostate cancer. Each patient was assigned with the risk score as follows: SLPI* 0.000584811158157081 + VSIG2 * -0.01190627068889 + CENPF * -0.317826812875334 + SLC7A1 * -0.0410213995358753 + SMC4 * 0.202544454923637 + ITPR2 * -0.0824652047622673 + TOP2A * 0.140312081524807 + OR51E2 * -0.00136602095885459. The GSVA revealed the biological features of CAFs, many cancer-related pathways, such as the adipocytokine signaling pathway, ERBB signaling pathway, GnRH signaling pathway, insulin signaling pathway, mTOR signaling pathway and PPAR signaling pathway are closely associated with CAFs. As a result of these observations, similar transcriptomics may be involved in the transition from normal fibroblasts to CAFs in adjacent tissues. As one of the biomarkers for CAFs, CENPF can promote the proliferation ability of prostate cancer cells. The overexpress of CENPF could promote the proliferation ability of prostate cancer cells. In conclusion, we discuss the potential prognostic and therapeutic value of CAF-dependent pathways in prostate cancer.

NCAPG2 promotes prostate cancer malignancy and stemness via STAT3/c-MYC signaling

CRABP2 Promotes Cell Migration and Invasion by Activating PI3K/AKT and MAPK Signalling Pathways Via Upregulating LAMB3 in Prostate Cancer

Identification of molecular subtypes and a prognostic signature based on chromatin regulators related genes in prostate cancer

CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling

SNHG3 could promote prostate cancer progression through reducing methionine dependence of PCa cells

NCAPD3 exerts tumor-promoting effects in prostatic cancer via dual impact on miR-30a-5p by STAT3-MALAT1 and MYC

Upregulation of COPB2 Promotes Prostate Cancer Proliferation and Invasion Through the MAPK/TGF-β Signaling Pathway

The circSPON2/miR-331-3p axis regulates PRMT5, an epigenetic regulator of CAMK2N1 transcription and prostate cancer progression

NCAPG2 Could Be an Immunological and Prognostic Biomarker: from Pan-Cancer Analysis to Pancreatic Cancer Validation

Prostate cancer stem cells and their targeted therapies

Elevated Expression Levels of PC3-Secreted Microprotein (PSMP) in Prostate Cancer Associated with Increased Xenograft Growth and Modification of Immune-Related Microenvironment

Tumor-associated Macrophages in Direct Contact with Prostate Cancer Cells Promote Malignant Proliferation and Metastasis Through NOTCH1 Pathway

p53-dependent CD51 expression contributes to characteristics of cancer stem cells in prostate cancer

The Established Chemokine-Related Prognostic Gene Signature in Prostate Cancer: Implications for Anti-Androgen and Immunotherapies

PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer

Mir-302/367/Lats2/yap Pathway is Essential for Prostate Tumor-Propagating Cells and Promotes the Development of Castration Resistance.

Decreased levels of PTCSC3 promote the deterioration of prostate cancer and affect the prognostic outcome of patients through sponge miR-182-5p

Identification of the novel therapeutic targets and biomarkers associated of prostate cancer with cancer-associated fibroblasts (CAFs)

NCAPG2 Promotes Tumour Proliferation by Regulating G2/M Phase and Associates with Poor Prognosis in Lung Adenocarcinoma

NCAPG promotes tumorigenesis of bladder cancer through NF-κB signaling pathway

Exploring the clinical and biological significance of the cell cycle-related gene CHMP4C in prostate cancer